RecruitingNCT07505342
Remote Assessments and Genetic Determinants of Myotonic Dystrophy
Studying Congenital muscular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Rochester
- Principal Investigator
- Johanna Hamel, MDUniversity of Rochester
- Enrollment
- 1000 enrolled
- Eligibility
- 18-88 years · All sexes
- Timeline
- 2022 – 2030
Study locations (1)
- University of Rochester, Rochester, New York, United States
Collaborators
Muscular Dystrophy Association · Myotonic Dystrophy Foundation (MDF) · National Institutes of Health (NIH)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07505342 on ClinicalTrials.govOther trials for Congenital muscular dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07125040Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease BiomarkersUniversità Vita-Salute San Raffaele
- RECRUITINGNCT06503367Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular DystrophyNationwide Children's Hospital
- RECRUITINGNCT06354790Natural History Study of Children With LAMA2-related DystrophiesInstitut de Myologie, France
- RECRUITINGNCT06924125Spanish Natural History Study for LAMA2 Muscular DystrophyHospital Universitari Vall d'Hebron Research Institute
- ACTIVE NOT RECRUITINGNANCT04038138Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI StudyCentre Hospitalier Universitaire de Nice
- RECRUITINGNCT01403402Congenital Muscle Disease Study of Patient and Family Reported Medical InformationCure CMD
- RECRUITINGNCT00138931Genetics of Cardiovascular and Neuromuscular DiseaseUniversity of Chicago